Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

A Series of Oral Lesions Presenting to an Otolaryngology Department.

Khan SU, O'Connor TE, Keogh IJ.

Ir Med J. 2015 Jun;108(6):177-9.

PMID:
26182801
2.

Role of inflammatory markers in Takayasu arteritis disease monitoring.

O'Connor TE, Carpenter HE, Bidari S, Waters MF, Hedna VS.

BMC Neurol. 2014 Mar 28;14:62. doi: 10.1186/1471-2377-14-62.

3.

Magnetic resonance imaging assessment of cerebral arteriovenous malformation obliteration after stereotactic radiosurgery.

OʼConnor TE, Friedman WA.

Neurosurgery. 2013 Nov;73(5):761-6. doi: 10.1227/NEU.0000000000000086.

PMID:
23863762
4.

Late onset laryngeal stenosis following radiotherapy for head and neck carcinoma: a case series.

Jayawardena J, O'Connor TE, White R, Chai F.

ANZ J Surg. 2012 Sep;82(9):657-8. doi: 10.1111/j.1445-2197.2012.06169.x. No abstract available.

PMID:
22943085
5.

Return to contact sports following infectious mononucleosis: the role of serial ultrasonography.

O'Connor TE, Skinner LJ, Kiely P, Fenton JE.

Ear Nose Throat J. 2011 Aug;90(8):E21-4.

PMID:
21853428
6.

Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke.

Mecca AP, Regenhardt RW, O'Connor TE, Joseph JP, Raizada MK, Katovich MJ, Sumners C.

Exp Physiol. 2011 Oct;96(10):1084-96. doi: 10.1113/expphysiol.2011.058578. Epub 2011 Jun 17.

7.

Laryngotracheoplasty to avoid tracheostomy in neonatal and infant subglottic stenosis.

O'Connor TE, Bilish D, Choy D, Vijayasekaran S.

Otolaryngol Head Neck Surg. 2011 Mar;144(3):435-9. doi: 10.1177/0194599810392180. Epub 2011 Jan 24.

PMID:
21493209
8.

Public knowledge of head and neck cancer.

O'Connor TE, Papanikolaou V, Keogh IJ.

Ir Med J. 2010 Apr;103(4):105-7.

PMID:
20486312
9.

Complications of otitis media in Indigenous and non-Indigenous children.

O'Connor TE, Perry CF, Lannigan FJ.

Med J Aust. 2009 Nov 2;191(9 Suppl):S60-4. Review.

PMID:
19883359
10.

Primary care management of otitis media among Australian children.

Gunasekera H, O'Connor TE, Vijayasekaran S, Del Mar CB.

Med J Aust. 2009 Nov 2;191(9 Suppl):S55-9.

PMID:
19883358
11.

Objective assessment of supraglottoplasty outcomes using polysomnography.

O'Connor TE, Bumbak P, Vijayasekaran S.

Int J Pediatr Otorhinolaryngol. 2009 Sep;73(9):1211-6. doi: 10.1016/j.ijporl.2009.05.007. Epub 2009 Jun 12.

PMID:
19524306
12.

Oesophageal foreign body and a double aortic arch: rare dual pathology.

O'Connor TE, Cooney T.

J Laryngol Otol. 2009 Dec;123(12):1404-6. doi: 10.1017/S0022215109005659. Epub 2009 May 27. Review.

PMID:
19470192
13.

Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion.

Mecca AP, O'Connor TE, Katovich MJ, Sumners C.

Exp Physiol. 2009 Aug;94(8):937-46. doi: 10.1113/expphysiol.2009.047936. Epub 2009 May 8.

14.
15.
16.

Patterns of cytokines released by peripheral blood leukocytes of normal donors and cancer patients during interleukin-2 activation in vitro.

Dupere S, Obiri N, Lackey A, Emma D, Yannelli J, Orr D, Birch R, O'Connor TE.

J Biol Response Mod. 1990 Apr;9(2):140-8.

PMID:
2111374
17.

Principles of biotherapy and its application to the treatment of disseminated renal cancer.

O'Connor TE, West WH, Marshall GD, Orr DW, Lewis M, Oldham RK.

Semin Surg Oncol. 1988;4(3):155-60. Review.

PMID:
3055159
18.
19.

Oncogenes: targets for immunodiagnosis and chemotherapy?

O'Connor TE.

Prog Clin Biol Res. 1985;172A:467-87.

PMID:
3991692
20.

Effects of divalent metal cations on composition and neoplasia-specific antigenicity of chromatins.

Dupere SL, Holland S, Gawne S, Cancelliere KE, Sedita BA, Dale PJ, Jarrell ED, O'Connor TE.

Cancer Res. 1983 Oct;43(10):4913-9.

21.

Molecular lesions associated with neoplasia: an introduction to proviruses, retroviruses, LTR's and onc genes.

O'Connor TE.

Prog Clin Biol Res. 1983;119:1-19. No abstract available.

PMID:
6867024
22.

Effects of polyethylene glycol on reverse transcriptase and other polymerase activities.

Chan EW, Dale PJ, Greco IL, Rose JG, O'Connor TE.

Biochim Biophys Acta. 1980 Feb 29;606(2):353-61.

PMID:
6153536
23.

Analytical techniques for cell fractions. XXVI. A two-dimentional electrophoretic analysis of basic proteins using phosphatidyl choline/urea solubilization.

Willard KE, Giometti CS, Anderson NL, O'Connor TE, Anderson NG.

Anal Biochem. 1979 Dec;100(2):289-98. No abstract available.

PMID:
525778
24.

Interruption of oncornavirus replication by modified rifamycin antibiotics.

O'Connor TE.

Ann N Y Acad Sci. 1977 Mar 4;284:544-65.

PMID:
81643
25.

Approaches to antiviral chemotherapy: a status report.

O'Connor TE.

Adv Pathobiol. 1976;(5):151-8. No abstract available.

PMID:
1053033
26.

Mammalian sarcoma-leukemia viruses. I. Infection of feline, bovine, and human cell cultures with Snyder-Theilen feline sarcoma virus.

Chan EW, Schiop-Stansly PE, O'Connor TE.

J Natl Cancer Inst. 1974 Feb;52(2):473-81. No abstract available.

PMID:
4361179
27.

Rescue of cell-transforming virus from a non-virus-producing bovine cell culture transformed by feline sarcoma virus.

Chan EW, Schiop-Stansly PE, O'Connor TE.

J Natl Cancer Inst. 1974 Feb;52(2):469-72. No abstract available.

PMID:
4361178
28.

Antiviral antibiotics: inhibition of focus-formation in human or mouse cell cultures by sarcoma-inducing oncornaviruses with rifamycins.

O'Connor TE, Schiop-Stansly P, Sethi VS, Hadidi A, Okano P.

Intervirology. 1974;3(1-2):63-83. No abstract available.

PMID:
4373409
29.

Molecular control program.

O'Connor TE.

Cancer Chemother Rep 3. 1973 May;4(3):79-82. No abstract available.

PMID:
4748876
30.

Reverse transcriptase-progress, problems and prospects.

O'Connor TE.

Bibl Haematol. 1973;39:1165-81. Review. No abstract available.

PMID:
4130390
31.

Infection and transformation of dog cells with a modified sarcoma virus.

Chapman AL, Fischinger PJ, O'Connor TE.

J Natl Cancer Inst. 1970 Nov;45(5):1047-53.

PMID:
18605433
32.

Replication of defective and competent forms of murine sarcoma virus in mouse cell cultures.

Fischinger PJ, O'Connor TE.

Virology. 1970 Jun;41(2):233-43. No abstract available.

PMID:
4316311
33.

Productive infection and morphologic alteration of human cells by a modified sarcoma virus.

Fischinger PJ, O'Connor TE.

J Natl Cancer Inst. 1970 Feb;44(2):429-38. No abstract available.

PMID:
11515085
34.

Effect of infection with Moloney sarcoma and leukemia viruses on nucleic acid synthesis in mouse cell cultures.

Hirschman SZ, Fischinger PJ, O'Connor TE.

J Natl Cancer Inst. 1970 Jan;44(1):107-16. No abstract available.

PMID:
11515020
35.

Physical alterations of a murine leukemia virus complex in mammalian cell cultures.

O'Connor TE, Fischinger PJ.

Bibl Haematol. 1970;(36):250-6. No abstract available.

PMID:
4142388
36.

The inhibition by cytosine arabinoside of the replication of murine leukemia and sarcoma viruses in mouse embryo cultures.

Hirschman SZ, Fischinger PJ, O'Connor TE.

Int J Cancer. 1969 Sep 15;4(5):671-7. No abstract available.

PMID:
4310640
37.

Radiation leukemia virus: quantitative tissue culture assay.

Fischinger PJ, O'Connor TE.

Science. 1969 Jul 18;165(3890):306-9.

PMID:
4306917
38.

Isolation and identification of a helper virus found in the Moloney sarcoma-leukemia virus complex.

Fischinger PJ, Moore CO, O'Connor TE.

J Natl Cancer Inst. 1969 Apr;42(4):605-22. No abstract available.

PMID:
5775808
39.

Effect of cytosine arabinoside on the replication of the Moloney sarcoma virus in 3T3 cell cultures.

Hirschman SZ, Fischinger PJ, Zaccari JJ, O'Connor TE.

J Natl Cancer Inst. 1969 Mar;42(3):399-411. No abstract available.

PMID:
5777489
40.

Virology: United States-Soviet Health Exchange visit 1967.

O'Connor TE.

Science. 1968 Aug 2;161(3840):492-3. No abstract available.

PMID:
4298199
41.

Tissue culture assay of helper activity of murine leukemia virus for murine sarcoma virus.

Fischinger PJ, O'Connor TE.

J Natl Cancer Inst. 1968 Jun;40(6):1199-212. No abstract available.

PMID:
4298946
42.
43.

Action of snake venom on Rauscher virus.

Monroe JH, Shibley GP, Schidlovsky G, Nakai T, Howatson AF, Wivel NW, O'Connor TE.

J Natl Cancer Inst. 1968 Jan;40(1):135-45. No abstract available.

PMID:
4169408
44.

Observations on the morphology of a murine leukemia virus (Rauscher) propagated in tissue culture.

Zeigel RF, Tyndall RL, O'Connor TE, Teeter E, Allen BV.

Natl Cancer Inst Monogr. 1966 Sep;22:237-63. No abstract available.

PMID:
5923318
45.

Murine leukemia viruses: rupture with ether and detergents to subviral constituents.

O'Connor TE, Rauscher FJ, De-Thé G, Fink MA, Gerber P.

Natl Cancer Inst Monogr. 1966 Sep;22:205-21. No abstract available.

PMID:
4288560
46.

Hemagglutination studies of the viral antigen in a murine leukemia (Rauscher).

Sibal LR, Fink MA, Vice JL, Brandt BL, O'Connor TE.

Proc Soc Exp Biol Med. 1966 Jun;122(2):591-6. No abstract available.

PMID:
4962939
47.

Murine leukemia viruses: antigenic studies by quantitative complement fixation.

Gerber P, O'Connor TE, Birch SM.

Science. 1966 May 20;152(3725):1074-5.

PMID:
4286616
48.

Structure of a murine leukemia virus after disruption with tween-ether and comparison with two myxoviruses.

De-Thé G, O'Connor TE.

Virology. 1966 Apr;28(4):713-28. No abstract available.

PMID:
5938890
49.

PHYSICAL INTERACTION OF A MURINE LEUKEMIA VIRUS WITH INFLUENZA VIRUS IN VITRO.

O'CONNOR TE, RAUSCHER FJ.

Science. 1964 Nov 6;146(3645):787-90.

PMID:
14197573
50.

DENSITY GRADIENT CENTRIFUGATION OF A MURINE LEUKEMIA VIRUS.

O'CONNOR TE, RAUSCHER FJ, ZEIGEL RF.

Science. 1964 May 29;144(3622):1144-7.

PMID:
14148438

Supplemental Content

Loading ...
Support Center